generic-timeline
Server Details
Whether a drug has a marketed generic today, and when its Orange Book protections lapse
- Status
- Healthy
- Uptime
- 100.0% over the last 24 hours
- Last Tested
- Transport
- Streamable HTTP · MCP 2024-11-05
- URL
- ChatGPT
- –
- Claude
- –
TDQS
Scored across 1 tool
With only one tool, there is no possibility of selecting the wrong tool; the tool's purpose is clearly described and distinct by virtue of being the only option.
The single tool name 'generic_availability_timeline' is clear, descriptive, and follows a consistent snake_case style, though there is no other tool to compare patterns against.
One tool is on the thin side, fitting the borderline category. The server's narrow purpose makes it acceptable, but it barely provides enough surface area to be considered well-scoped.
The tool answers the core generic availability question effectively, including price dispersion and earliest patent expiry. However, a 'timeline' server might be expected to provide more comprehensive data, such as all expiry dates or exclusivity details, representing a minor gap.
Available Tools
1 toolgeneric_availability_timelineAInspect
For a US prescription drug, report whether a real MARKETED generic exists today — judged on CMS NADAC price dispersion across NDCs of one drug identity, not on FDA approval counts, because an approved generic that nobody sells does not lower anyone's price. Returns the price range for the identical pill when a generic is marketed, and when one is not, the earliest expiry among listed FDA Orange Book patents and exclusivities. NEVER presents a patent expiry as a launch date. Pediatric exclusivity (21 U.S.C. 355a) is honoured, which moves some dates six months later than naive de-duplication produces.
Inputs: drug (required).
Tool Schema Changelog
Recent tool additions, removals, and schema changes observed during successful MCP inspections.
Loading tool schema changelog…
Related MCP Connectors
Orange Book competitive intelligence from FDA's monthly official data ZIP.
Drug patent expiries ranked by the Medicare Part D spending exposed to them
US drug products at FDA product-NDC grain with source-linked enrichments.
CMS Medicare drug price negotiation: the Maximum Fair Price (MFP) for every drug CMS has selected…
Related MCP Servers
- AlicenseNot gradedqualityCmaintenanceEnables searching and analyzing FDA Orange Book data for drug competition, including products, patents, and exclusivities.8 npmMIT
- AlicenseNot gradedqualityDmaintenanceProvides comprehensive pharmaceutical intelligence by integrating real-time openFDA data with locally-cached Orange Book and Purple Book databases. It enables users to analyze drug safety, patents, generic equivalents, biosimilars, and regulatory information through natural language queries.4MIT
- AlicenseNot gradedqualityDmaintenanceProvides unified access to drug formulary data from US ACA marketplace health insurance plans, enabling drug search, coverage details, restriction info, and plan comparison across thousands of plans.MIT
- AlicenseAqualityBmaintenanceEnables AI assistants to check the live FDA drug shortage database by generic name, brand name, active ingredient or NDC, returning current status, availability, shortage reasons and package-level details. Also supports browsing recently updated listings and counting shortages by status, therapeutic category or distinct product.4MIT
Glama MCP Gateway
Add one secure layer between your agents and this server.